Home

Alexander Cumbo

CIK 1685994 · President and CEO · last filed 2026-06-12

Alexander Cumbo is a President and CEO who has filed 46 SEC Form 4 insider transactions across 6 companies since 2017. The most recent filing, for VOR, was dated Jun 12, 2026. Across all open-market trades the lifetime net is −$13.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.95M

Companies

6

Total Filings

46

Lifetime Open-Market Net

-$13.38M

Filer Profile

Reported Address
215 FIRST STREET
SUITE 415
CAMBRIDGE, MA 02142
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VOR Director — $18.42 — $0 2 2026-06-12
Climb Bio, Inc. (ELYM) Delisted Director — $5.11 — $0 3 2026-06-08
SLDB President and CEO 235,405 $7.33 $1.73M -$1.12M 12 2026-04-21
Verve Therapeutics, Inc. (VERV) Delisted Director — $11.13 — $0 5 2025-07-28
Ra Pharmaceuticals, Inc. (RARX) Delisted Director — — — $0 3 2020-04-03
SRPT EVP, Chief Commercial Officer 12,008 $18.71 $224.7K -$12.25M 14 2020-02-28

Recent Filings

46 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-12 VOR Grant (A) — $0 EDGAR
2026-06-08 Climb Bio, Inc. (ELYM) Delisted Grant (A) — $0 EDGAR
2026-04-21 SLDB Grant (A) — $0 EDGAR
2026-02-18 SLDB Mixed +13,387 -$96.9K EDGAR
2026-02-18 SLDB Notice (144) −16,644 -$96.9K EDGAR
2026-02-06 SLDB Sell (S) −48,913 -$315.1K EDGAR
2026-02-04 SLDB Notice (144) −48,913 -$315.1K EDGAR
2026-02-02 SLDB Mixed +189,543 -$516.6K EDGAR
2026-02-02 SLDB Notice (144) −80,258 -$516.6K EDGAR
2025-12-04 SLDB Mixed +17,804 -$55.2K EDGAR
Showing 1–10 of 46
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.